Form 4 for DHR Danaher Corporation
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0000313616-22-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-02 | 2022-02-01 | DHR | Weidemanis Joakim | EVP | F - Tax | $287.29 | -5,014 | 58.8K | -8% | -$1.44M |
| D | 2022-02-02 | 2022-01-31 | DHR | Weidemanis Joakim | EVP | M - OptEx | $46.13 | +20.5K | 84.4K | +32% | +$946.0K |
| D | 2022-02-02 | 2022-01-31 | DHR | Weidemanis Joakim | EVP | S - Sale+OE | $285.24 | -20.5K | 63.8K | -24% | -$5.85M |
| D | 2022-02-02 | 2022-01-31 | DHR | Weidemanis Joakim | EVP | M - OptEx | $0.00 | -20.5K | 0 | -100% | $0 |
| D | 2022-02-02 | 2022-02-01 | DHR | Weidemanis Joakim | EVP | A - Grant | $329.01 | +512.10 | 13.4K | +4% | +$168.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | F | D | 5,014 | $287.29 | 58,829 | D | — | — | (F2) This transaction relates to the withholding of certain shares for tax purposes in connection with the distribution of performance-based restricted stock units. |
| 2 | Common | Common Stock | 2022-01-31 | M | A | 20,508 | $46.13 | 84,351 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-31 | S | D | 20,508 | $285.24 | 63,843 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.060 to $285.350, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. |
| 4 | Derivative | Employee stock option (right to buy) | 2022-01-31 | M | D | 20,508 | $0.00 | 0 | D | $46.13 · — to 2023-02-21 | 20,508 Common Stock | (F3) One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was February 21, 2013. |
| 5 | Derivative | Danaher Deferred Compensation Programs - Danaher Stock Fund | 2022-02-01 | A | A | 512.10 | $329.01 | 13,392.23 | D | $0.00 · — to — | 512.10 Common Stock | (F4) Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account. (F5) The notional shares convert on a one-for-one basis. (F6) The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. |